Colonics
About Me
Recent Posts
- 4 Mushroom Poisonings In 2 Weeks - Doctors Test Milk Thistle As Treatment
- Improved Diagnostics For Sleeping Sickness
- Prostate Growth May Be Slowed By Statins
- New Tools For Psychological Science Research - Facebook And Smartphones
- Finding That Oxytocin Improves Brain Function In Children With Autism Could Lead To Treatment For Associated Social Deficits
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
Friends
Links
Entry 1 of 2380
Last Page | Next Page
6/25/2009
-
Preclinical Proof-of-Concept Studies Published For Novavax Seasonal Influenza Virus-Like-Particle Vaccine
|
Novavax, Inc. (Nasdaq: NVAX) announced ventilation of the preclinical study results that supported the clinical growth of the company's investigational VLP vaccine against the H3N2, H1N1 and B pandemic strains. The study, which was conducted by scientists from the health center of Pittsburgh, Center for Vaccine investigation and Novavax, was published in the June 24, 2009 online issue of PLoS ONE. More: - Brought to my attention by |
Post A Comment! :: Send to a Friend! |
Share and enjoy
